Risk Clinical Stratification of Sickle Cell Disease in Nigeria, Assessment of Efficacy/Safety of Hydroxyurea Treatment
- Status
- COMPLETED
- Phase
- PHASE4
Clinical Trials Related to Sickle Cell Disease
Related studies linked through entity extraction aliases.
Medication Adherence in Youth With Sickle Cell Disease (SCD)
- Status
- COMPLETED
- Phase
- N/A
A Study Evaluating the Safety and Efficacy of Lovo-cel in Severe Sickle Cell Disease
- Status
- COMPLETED
- Phase
- PHASE1/PHASE2
Use of Mobile Technology for Intensive Training in Medication Management
- Status
- COMPLETED
- Phase
- NA
PATient Navigator to rEduce Readmissions
- Status
- COMPLETED
- Phase
- NA
Nonmyeloablative Peripheral Blood Mobilized Hematopoietic Precursor Cell Transplantation for Sickle Cell Disease and Beta-thalassemia in People With Higher Risk of Transplant Failure
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE2
Feasibility Study of Unfractionated Heparin in Acute Chest Syndrome
- Status
- TERMINATED
- Phase
- PHASE2
Sickle Cell Clinical Research and Intervention Program
- Status
- RECRUITING
- Phase
- N/A
Measurement of Cerebral Blood Flow Using Transcranial Doppler Ultrasound in Children With Sickle Cell Disease
- Status
- COMPLETED
- Phase
- NA
Hematopoietic Stem Cell Transplant for Sickle Cell Disease
- Status
- COMPLETED
- Phase
- PHASE1
Inhaled Mometasone to Reduce Painful Episodes in Patients With Sickle Cell Disease
- Status
- COMPLETED
- Phase
- PHASE2
Novel Dose Escalation to Predict Treatment With Hydroxyurea
- Status
- COMPLETED
- Phase
- EARLY_PHASE1
Efficacy and Safety of Ferriprox® in Patients With Sickle Cell Disease or Other Anemias
- Status
- TERMINATED
- Phase
- PHASE4
Hydroxyurea Adherence for Personal Best in Sickle Cell Treatment: HABIT
- Status
- COMPLETED
- Phase
- NA
SCD-Haplo: Phase II Study of HLA-Haploidentical SCT for Aggressive SCD
- Status
- TERMINATED
- Phase
- PHASE2
Propanolol and Red Cell Adhesion Non-asthmatic Children Sickle Cell Disease
- Status
- TERMINATED
- Phase
- PHASE1
Liver Fibrosis in Sickle Cell Disease
- Status
- COMPLETED
- Phase
- N/A
Losartan for Sickle Cell Kidney Disease
- Status
- COMPLETED
- Phase
- EARLY_PHASE1
Evaluation of Different Dose Regimens of Aes-103 Given for 28 Days to Subjects With Stable Sickle Cell Disease
- Status
- TERMINATED
- Phase
- PHASE2
Novel Use Of Hydroxyurea in an African Region With Malaria
- Status
- COMPLETED
- Phase
- PHASE3